Regulatory Science and the Development of a COVID-19 Vaccine
MBP Assistant Director of Research Arthur Felse explains the regulatory approval process and why it s important not to rush any new preventative therapies.
Dec 11, 2020
In less than nine months, more than 60 million people worldwide have tested positive for COVID-19 and nearly 1.5 million people have died. The numbers are staggering in the United States, where there have been more than 15 million cases and more than 283,000 deaths.
As the world awaits an approved vaccine, many people wonder why the process is taking so long. Arthur Felse, the assistant director of research for Northwestern Engineering s Master of Biotechnology Program (MBP), recognizes the public s anxiousness for a preventative measure. He also understands that something like this takes time, and rushing through the testing and registration process could actually prove even more consequential.